Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X

Heart

Volumn 96, Issue 15, 2010, Pages 1227-1232

  Huang, Shao Sung ^a,b   Huang, Po Hsun ^a,b   Leu, Hsin Bang ^a,b   Wu, Tao Cheng ^a,b   Lin, Shing Jong ^a,b   Chen, Jaw Wen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; DEATH; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYNDROME X; UNSTABLE ANGINA PECTORIS;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; LIPIDS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; OXIDATIVE STRESS; PROGNOSIS; SUPEROXIDES;

EID: 77954692327     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.192393     Document Type: Article

References (32)

1. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004;90:457-63. (Pubitemid 38406928)
2. Arroyo-Espliguero R, Kaski JC. Microvascular dysfunction in cardiac syndrome X: the role of inflammation. CMAJ 2006;174:1833.
3. Chauhan A, Mullins PA, Petch MC, et al. Is coronary flow reserve in response to papaverine really normal in syndrome X? Circulation 1994;89:1998-2004.
4. Chauhan A, Mullins PA, Thuraisingham SI, et al. Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol 1994;24:329-35. (Pubitemid 24246529)
5. Frøbert O, Mølgaard H, Bøtker HE, et al. Autonomic balance in patients with angina and a normal coronary angiogram. Eur Heart J 1995;16:1356-60.
6. Egashira K, Inou T, Hirooka Y, et al. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993;328:1659-64. (Pubitemid 23157347)
7. Lanza GA, Andreotti F, Sestito A, et al. Platelet aggregability in cardiac syndrome X. Eur Heart J 2001;22:1924-30.
8. Chen JW, Hsu NW, Ting CT, et al. Differential coronary hemodynamics and left ventricular contractility in patients with syndrome X. Int J Cardiol 2000;75:49-57.
9. Arroyo-Espliguero R, Mollichelli N, Avanzas P, et al. Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J 2003;24:2006-11. (Pubitemid 37420447)
10. Buffon A, Rigattieri S, Santini SA, et al. Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X. Am J Physiol Heart Circ Physiol 2000;279:H2627-33.
11. Leu HB, Lin CP, Lin WT, et al. Circulating mononuclear superoxide production and inflammatory markers for long-term prognosis in patients with cardiac syndrome X. Free Radic Biol Med 2006;40:983-91.
12. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-6.
13. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci U S A 1987;84:5918-22.
14. Stocker R, Peterhans E. Antioxidant properties of conjugated bilirubin and biliverdin: biologically relevant scavenging of hypochlorous acid. Free Radic Res Commun 1989;6:57-66.
15. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
16. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994;269:16712-19.
17. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with risk of coronary artery disease. Clin Chem 1994;40:18-23.
18. Kawamura K, Ishikawa K, Wada Y, et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 2005;25:155-60. (Pubitemid 40054269)
19. Chen JW, Hsu NW, Wu TC, et al. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 2002;90:974-82.
20. Pizzi C, Manfrini O, Fontana F, et al. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. Circulation 2004;109:53-8.
21. Ridker PM, Danielson E, Fonseca FA, et al. Jupiter Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.
22. Merz NB, Johnson BD, Kelsey PSF, et al. Wise Study Group. Women's ischemia syndrome evaluation. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care 2001;7:959-65.
23. Kaski JC, Rosano GM, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
24. Bugiardini R, Manfrini O, Pizzi C, et al. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004;109:2518-23. (Pubitemid 38720550)
25. Targonski PV, Bonetti PO, Pumper GM, et al. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 2003;107:2805-9.
26. Cannon RO 3rd. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms. J Am Coll Cardiol 2009;54:877-85.
27. Leopold JA, Loscalzo J. Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol 2005;25:1332-40.
28. Ishikawa K, Navab M, Leitinger N, et al. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 1997;100:1209-16.
29. Ollinger R, Bilban M, Erat A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 2005;112:1030-9.
30. Lindenblatt N, Bordel R, Schareck W, et al. Vascular heme oxygenase-1 induction suppresses microvascular thrombus formation in vivo. Arterioscler Thromb Vasc Biol 2004;24:601-6.
31. Perlstein TS, Pande RL, Creager MA, et al. Serum Total Bilirubin Level, Prevalent Stroke, and Stroke Outcomes: NHANES 1999-2004. Am J Med 2008;121:781-8.
32. Perlstein TS, Pande RL, Beckman JA, et al. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008;28:166-72.